These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

539 related articles for article (PubMed ID: 28329215)

  • 21. Dual (Anticoagulant Plus Single Antiplatelet) vs Triple (Anticoagulant Plus Dual Antiplatelet) Antithrombotic Therapy - "Real World" Experience.
    Effron MB; Gibson CM
    Prog Cardiovasc Dis; 2018; 60(4-5):531-536. PubMed ID: 29360524
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomised controlled trial to investigate optimal antithrombotic therapy in patients with non-valvular atrial fibrillation undergoing percutaneous coronary intervention: a study protocol of the OPTIMA-AF trial.
    Sotomi Y; Kozuma K; Kashiwabara K; Higuchi Y; Ando K; Morino Y; Ako J; Tanabe K; Muramatsu T; Nakazawa G; Hikoso S; Sakata Y;
    BMJ Open; 2021 Dec; 11(12):e048354. PubMed ID: 34907043
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety and Efficacy of Oral Anticoagulants Therapies in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Network Meta-Analysis.
    Mainka FF; Ferreira VL; Mendes AM; Marques GL; Fernandez-Llimos F; Tonin FS; Pontarolo R
    J Cardiovasc Pharmacol Ther; 2020 Sep; 25(5):399-408. PubMed ID: 32489116
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combining Oral Anticoagulants With Platelet Inhibitors in Patients With Atrial Fibrillation and Coronary Disease.
    Sindet-Pedersen C; Lamberts M; Staerk L; Nissen Bonde A; Berger JS; Pallisgaard JL; Lock Hansen M; Torp-Pedersen C; Gislason GH; Olesen JB
    J Am Coll Cardiol; 2018 Oct; 72(15):1790-1800. PubMed ID: 30286922
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Triple oral antithrombotic therapy in atrial fibrillation and coronary artery stenting.
    Reed GW; Cannon CP
    Clin Cardiol; 2013 Oct; 36(10):585-94. PubMed ID: 23873635
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention.
    Lamberts M; Gislason GH; Olesen JB; Kristensen SL; Schjerning Olsen AM; Mikkelsen A; Christensen CB; Lip GY; Køber L; Torp-Pedersen C; Hansen ML
    J Am Coll Cardiol; 2013 Sep; 62(11):981-9. PubMed ID: 23747760
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antithrombotic Therapy After Percutaneous Coronary Intervention in Atrial Fibrillation: The Triple Trouble.
    Leggio M; Fusco A; Severi P; Lombardi M; Caldarone E; D'Emidio S; Armeni M; Mereu D; Bendini MG; Mazza A
    Drugs; 2018 Sep; 78(13):1309-1319. PubMed ID: 30132258
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Triple, dual, and single antithrombotic therapy for patients with atrial fibrillation undergoing percutaneous coronary intervention.
    Saito Y; Kobayashi Y
    Cardiovasc Interv Ther; 2020 Jan; 35(1):44-51. PubMed ID: 31281936
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Duration of Triple Antithrombotic Therapy and Outcomes Among Patients Undergoing Percutaneous Coronary Intervention.
    Koskinas KC; Räber L; Zanchin T; Pilgrim T; Stortecky S; Hunziker L; Blöchlinger S; Billinger M; Gartwyl F; Moro C; Moschovitis A; Jüni P; Heg D; Windecker S
    JACC Cardiovasc Interv; 2016 Jul; 9(14):1473-83. PubMed ID: 27478115
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antithrombotic regimens in patients with indication for long-term anticoagulation undergoing coronary interventions-systematic analysis, review of literature, and implications on management.
    Deshmukh A; Hilleman DE; Del Core M; Nair CK
    Am J Ther; 2013; 20(6):654-63. PubMed ID: 21519218
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antithromboembolic Strategies for Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention.
    Ather A; Laliberte B; Reed BN; Schenk A; Watson K; Devabhakthuni S; See VY
    Am J Cardiovasc Drugs; 2018 Dec; 18(6):441-455. PubMed ID: 29915905
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Management of antithrombotic therapy in patients with bleeding after percutaneous coronary intervention].
    Capranzano P; Francaviglia B; Capodanno D; Tamburino C
    G Ital Cardiol (Rome); 2020 Feb; 21(2 Suppl 1):34S-41S. PubMed ID: 32134406
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atrial Fibrillation and Coronary Artery Disease: A Long-Term Perspective on the Need for Combined Antithrombotic Therapy.
    Fanaroff AC; Li S; Marquis-Gravel G; Giri J; Lopes RD; Piccini JP; Wang TY
    Circ Cardiovasc Interv; 2021 Dec; 14(12):e011232. PubMed ID: 34932388
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anticoagulation strategies in patients with atrial fibrillation after PCI or with ACS : The end of triple therapy?
    Fluschnik N; Becher PM; Schnabel R; Blankenberg S; Westermann D
    Herz; 2018 Feb; 43(1):20-25. PubMed ID: 29188358
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antithrombotic Treatment after Carotid Stenting in Patients with Concomitant Atrial Fibrillation.
    Pardo-Galiana B; Medina-Rodriguez M; Millan-Vazquez M; Cabezas-Rodriguez JA; Lebrato-Hernandez L; Ainz-Gomez L; Zapata-Arriaza E; Ortega J; de Albóniga-Chindurza A; Montaner J; Gonzalez A; Moniche F
    AJNR Am J Neuroradiol; 2022 May; 43(5):727-730. PubMed ID: 35393364
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antithrombotics: From Aspirin to DOACs in Coronary Artery Disease and Atrial Fibrillation (Part 3/5).
    Verheugt FWA; Ten Berg JM; Storey RF; Cuisset T; Granger CB
    J Am Coll Cardiol; 2019 Aug; 74(5):699-711. PubMed ID: 31277840
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and efficacy of non-vitamin K oral anticoagulant for atrial fibrillation patients after percutaneous coronary intervention: A bivariate analysis of the PIONEER AF-PCI and RE-DUAL PCI trial.
    Chi G; Kerneis M; Kalayci A; Liu Y; Mehran R; Bode C; Halperin JL; Verheugt FWA; Wildgoose P; van Eickels M; Lip GYH; Cohen M; Peterson ED; Fox KAA; Gibson CM
    Am Heart J; 2018 Sep; 203():17-24. PubMed ID: 30015064
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention: A North American Perspective: 2021 Update.
    Angiolillo DJ; Bhatt DL; Cannon CP; Eikelboom JW; Gibson CM; Goodman SG; Granger CB; Holmes DR; Lopes RD; Mehran R; Moliterno DJ; Price MJ; Saw J; Tanguay JF; Faxon DP
    Circulation; 2021 Feb; 143(6):583-596. PubMed ID: 33555916
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atrial fibrillation, bleeding, and coronary intervention: current recommendations.
    Farhan S; Mehran R
    Coron Artery Dis; 2017 Dec; 28(8):702-709. PubMed ID: 28938240
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of single vs dual antiplatelet therapy in patients on anticoagulation undergoing percutaneous coronary intervention: A systematic review and meta-analysis.
    Atti V; Turagam MK; Garg J; Velagapudi P; Patel NJ; Basir MB; Mujer MT; Rayamajhi S; Abela GS; Koerber S; Gopinnathanair R; Lakkireddy D
    J Cardiovasc Electrophysiol; 2019 Nov; 30(11):2460-2472. PubMed ID: 31432607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.